Structures by: Lough A. J.
Total: 939
Bis-(2-naphthoato)-1,4,8,11-tetraazacyclotetradecanenickel(II)
C32H38N4NiO4
Acta Crystallographica Section B (2002) 58, 1 78-93
a=11.4970(4)Å b=10.6563(4)Å c=11.9407(4)Å
α=90.00° β=92.2080(17)° γ=90.00°
Bis-(3,5-dinitrobenzoato)-1,4,8,11-tetraazacyclotetradecanenickel(II)
C24H30N8NiO12
Acta Crystallographica Section B (2002) 58, 1 78-93
a=7.7663(3)Å b=9.7845(6)Å c=10.4026(7)Å
α=99.826(2)° β=97.966(2)° γ=108.388(2)°
Bis-(3-hydroxybenzoato)-1,4,8,11-tetraazacyclotetradecanenickel(II)
C24H34N4NiO6
Acta Crystallographica Section B (2002) 58, 1 78-93
a=8.5180(3)Å b=13.2496(5)Å c=10.7720(4)Å
α=90.00° β=101.161(2)° γ=90.00°
Bis-(4-nitrobenzoato)-1,4,8,11-tetraazacyclotetradecanenickel(II)
C24H32N6NiO8
Acta Crystallographica Section B (2002) 58, 1 78-93
a=12.8106(3)Å b=8.4187(2)Å c=12.8397(4)Å
α=90.00° β=114.2543(10)° γ=90.00°
Bis-(4-aminobenzoato)-1,4,8,11-tetraazacyclotetradecanenickel(II)
C24H36N6NiO4
Acta Crystallographica Section B (2002) 58, 1 78-93
a=18.4430(4)Å b=8.4149(2)Å c=16.8262(4)Å
α=90.00° β=107.8774(14)° γ=90.00°
[Aqua-(5-hydroxyisophthalato)-1,4,8,11- tetraazacyclotetradecanenickel(II)] tetrahydrate
C18H30N4NiO6,4(H2O)
Acta Crystallographica Section B (2002) 58, 1 78-93
a=18.4057(8)Å b=9.6927(4)Å c=13.4648(5)Å
α=90.00° β=96.724(2)° γ=90.00°
2(C15H25N4NiO4),C10H28N4NiO2,2(ClO4),0.86(H2O)
2(C15H25N4NiO4),C10H28N4NiO2,2(ClO4),0.86(H2O)
Acta Crystallographica Section B (2002) 58, 1 78-93
a=10.8295(3)Å b=16.9416(5)Å c=14.9596(5)Å
α=90.00° β=93.6260(13)° γ=90.00°
1,2-Bis-(4'-pyridyl)ethene--racemic tartaric acid (1/1)
C16H16N2O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=8.8780(11)Å b=9.6130(13)Å c=10.1020(13)Å
α=73.665(7)° β=66.433(8)° γ=79.141(6)°
1,2-Bis-(4'-pyridyl)ethene--(2R,3R)-tartaric acid (1/)
C12H11N2,C12H10N2,C4H6O6,C4H5O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=8.6195(3)Å b=9.5654(4)Å c=9.8727(4)Å
α=103.1622(18)° β=109.9123(18)° γ=90.262(3)°
4,4'-Bipyridyl--racemic tartaric acid (1/1)
C10H9N2,C4H5O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=4.7847(2)Å b=10.2505(5)Å c=13.8412(8)Å
α=99.434(2)° β=91.252(2)° γ=96.163(2)°
4,4'-Bipyridyl--(2R,3R)-tartaric acid (1/1)
C14H14N2O6
Acta Crystallographica Section B (2002) 58, 2 272-288
a=10.4430(13)Å b=4.4665(6)Å c=14.110(2)Å
α=90.00° β=92.954(5)° γ=90.00°
Piperazine--racemic tartaric acid (1/2)
C4H12N2,2(C4H5O6)
Acta Crystallographica Section B (2002) 58, 2 272-288
a=6.5439(3)Å b=15.7915(8)Å c=7.5357(4)Å
α=90.00° β=94.484(2)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--racemic tartaric acid (1/2)
(C6H13N2),2(C4H5.5O6)
Acta Crystallographica Section B (2002) 58, 2 272-288
a=7.32400(10)Å b=15.9935(3)Å c=7.51490(10)Å
α=90.00° β=94.4050(11)° γ=90.00°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane--3,5- dinitrobenzoic acid(1/2)
C16H38N4,2(C7H3N2O6)
Acta Crystallographica Section B (2000) 56, 6 1054-1062
a=8.7336(3)Å b=10.9388(3)Å c=11.0284(3)Å
α=114.5800(17)° β=91.9660(18)° γ=111.6740(18)°
Racemic-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetraazacyclotetradecane--5- hydroxyisophthalic acid--water (1/1/1)
C16H38N4,C8H4O5,H2O
Acta Crystallographica Section B (2000) 56, 6 1054-1062
a=16.0262(4)Å b=11.6461(3)Å c=15.7907(3)Å
α=90.00° β=118.6520(12)° γ=90.00°
Dimethylamine--ferrocene-1,1'-dicarboxylic acid (1/1)
C12H9FeO4,C2H8N
Acta Crystallographica Section B (2002) 58, 5 786-802
a=30.9616(7)Å b=7.8147(2)Å c=12.1521(3)Å
α=90.00° β=109.7090(12)° γ=90.00°
Morpholine--ferrocene-1,1'-dicarboxylic acid--water (2/1/1)
C12H8FeO4,2(C4H10NO),H2O
Acta Crystallographica Section B (2002) 58, 5 786-802
a=7.4018(2)Å b=9.2018(3)Å c=30.3884(11)Å
α=90.00° β=101.0630(15)° γ=90.00°
4,4'-Bipyridyl--ferrocene-1,1'-dicarboxylic acid (1/1)
C12H10FeO4,C10H8N2
Acta Crystallographica Section B (2002) 58, 5 786-802
a=6.9500(2)Å b=10.7645(3)Å c=12.5260(4)Å
α=97.8780(11)° β=92.0960(11)° γ=102.9980(13)°
Octylamine--ferrocene-1,1'-dicarboxylic acid (2/1)
2(C8H20N),C12H8FeO4
Acta Crystallographica Section B (2002) 58, 5 786-802
a=6.3490(2)Å b=9.6089(4)Å c=12.1674(4)Å
α=98.738(2)° β=100.380(2)° γ=91.2290(17)°
Piperidine--ferrocene-1,1'-dicarboxylic acid (1/1)
C12H9FeO4,C5H12N
Acta Crystallographica Section B (2002) 58, 5 786-802
a=5.9880(3)Å b=19.4750(12)Å c=13.4340(9)Å
α=90° β=99.058(3)° γ=90°
Tris-(2-aminoethyl)amine--ferrocene-1,1'-dicarboxylic acid (2/3)
2(C6H21N4),3(C12H8FeO4)
Acta Crystallographica Section B (2002) 58, 5 786-802
a=9.7360(19)Å b=13.661(3)Å c=22.855(5)Å
α=97.51(3)° β=99.09(3)° γ=91.11(3)°
Tyramne--ferrocene-1,1'-dicarboxylic acid (2/1)
C12H8FeO4,2(C8H12NO)
Acta Crystallographica Section B (2002) 58, 5 786-802
a=12.6828(4)Å b=13.2119(4)Å c=14.3107(4)Å
α=64.4870(14)° β=68.4460(12)° γ=72.2550(15)°
Benzene-1,2,4,5-tetracarboxylic acid--4,4'-bipyridyl (1/2)
C10H4O8,2(C10H9N2)
Acta Crystallographica Section B (2000) 56, 2 261-272
a=7.3974(3)Å b=9.6352(4)Å c=10.1688(3)Å
α=64.872(2)° β=72.375(2)° γ=76.612(2)°
Benzeme-1,2,4,5-tetracarboxylic acid--hexamethylenetetramine (1/2)
C10H4O8,2(C6H13N4)
Acta Crystallographica Section B (2000) 56, 2 261-272
a=9.7029(6)Å b=10.9369(7)Å c=16.7647(11)Å
α=84.271(3)° β=79.399(3)° γ=75.264(3)°
3,6,9,16,19,22-Hexa-azatricyclo[22.2.2.211,14]triconta-1(26),11(29), 12,14(30),24,27-hexaene -- 4,4'-Biphenol --Water (1/3/2)
C24H40N6,C12H10O2,2(C12H9O2),2(H2O)
Acta Crystallographica Section B (2000) 56, 2 287-298
a=12.3442(4)Å b=7.6496(3)Å c=29.1745(9)Å
α=90.00° β=110.686(2)° γ=90.00°
3,6,9,16,19,22-Hexa-azatricyclo[22.2.2.211,14]triconta-1(26),11(29), 12,14(30),24,27-hexaene -- 4,4'-Sulfonyldiphenol (1/2)
C24H40N6,2(C12H9O4S)
Acta Crystallographica Section B (2000) 56, 2 287-298
a=18.0527(5)Å b=13.1074(2)Å c=20.5723(5)Å
α=90.00° β=108.2524(11)° γ=90.00°
Piperazine-ethane-1,2-diphosphonic acid (1/1)
C4H12N2,C2H6O6P2
Acta Crystallographica Section B (2001) 57, 1 95-102
a=7.3914(6)Å b=9.3343(7)Å c=9.3590(6)Å
α=90.00° β=107.291(4)° γ=90.00°
4,4'-trimethylenedipiperidine-ethane-1,2-diphosphonic acid-water (1/1/2.8).
(C13H28N2),(C2H6O6P2),2.8(H2O)
Acta Crystallographica Section B (2001) 57, 1 95-102
a=6.1218(2)Å b=20.6215(7)Å c=18.1831(7)Å
α=90.00° β=99.942(2)° γ=90.00°
C48H24B2N12O,2(C6H4Cl2)
C48H24B2N12O,2(C6H4Cl2)
Acta Crystallographica Section B (2012) 68, 6 636-645
a=11.3894(3)Å b=13.2623(3)Å c=17.6618(6)Å
α=78.3470(16)° β=85.6160(13)° γ=76.7400(17)°
C48H24B2N12O
C48H24B2N12O
Acta Crystallographica Section B (2012) 68, 6 636-645
a=25.6932(18)Å b=8.3375(5)Å c=20.8860(16)Å
α=90.00° β=124.401(3)° γ=90.00°
C48H24B2N12O,0.25(H2O)
C48H24B2N12O,0.25(H2O)
Acta Crystallographica Section B (2012) 68, 6 636-645
a=10.4180(3)Å b=13.4413(6)Å c=13.9207(6)Å
α=87.5640(19)° β=77.298(2)° γ=88.101(3)°
1,4-Diazabicyclo[2.2.2]octane--3,5-dihydroxybenzoic acid--water (1/1/1)
C6H13N2,C7H5O4,H2O
Acta Crystallographica Section B (2001) 57, 3 329-338
a=9.4478(4)Å b=11.7644(4)Å c=25.9024(12)Å
α=90° β=101.969(2)° γ=90°
3,5-Dinitrobenzoic acid--1,4-diazabicyclo[2.2.2]octane--water (2/1/0.13)
C6H13N2,C7H4N2O6,C7H3N2O6,0.13(H2O)
Acta Crystallographica Section B (2001) 57, 2 201-212
a=11.6228(4)Å b=10.4320(3)Å c=19.6350(6)Å
α=90.00° β=109.6890(18)° γ=90.00°
3,5-Dinitrobenzoic acid--1,2-diaminoethane (2/1)
2(C7H3N2O6),C2H10N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=5.4549(2)Å b=10.6869(4)Å c=17.4420(6)Å
α=90.00° β=95.704(2)° γ=90.00°
3,5-Dinitrobenzoic acid--piperazine (2/1)
2(C7H3N2O6),C4H12N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=6.6970(5)Å b=9.1655(8)Å c=10.5942(9)Å
α=65.338(3)° β=85.985(4)° γ=69.313(3)°
3,5-Dinitrobenzoic acid--N,N,N',N'-tetramethylethylenediamine (2/1)
2(C7H3N2O6),C6H18N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=6.0665(2)Å b=9.0635(3)Å c=21.8452(6)Å
α=90.00° β=92.031(2)° γ=90.00°
3,5-Dinitrobenzoic acid--N,N'-dimethylpiperazine (2/1)
2(C7H3N2O6),C6H16N2
Acta Crystallographica Section B (2001) 57, 2 201-212
a=7.1399(2)Å b=21.1749(6)Å c=7.8255(2)Å
α=90.00° β=99.1990(18)° γ=90.00°
3,5-Dinitrobenzoic acid--1,2-bis(4'-pyridyl)ethane (2/1)
C12H13N2,C14H7N4O12
Acta Crystallographica Section B (2001) 57, 2 201-212
a=10.1344(6)Å b=4.9420(2)Å c=27.5984(14)Å
α=90.00° β=110.960(2)° γ=90.00°
3,5-Dinitrobenzoic acid--trans-1,2-bis(4'-pyridyl)ethene (2/1)
C12H12N2,2(C7H3N2O6)
Acta Crystallographica Section B (2001) 57, 2 201-212
a=4.7297(3)Å b=9.3973(6)Å c=14.8365(6)Å
α=104.528(3)° β=94.086(3)° γ=92.793(3)°
Piperazinee--3,5-dihydroxybenzoic acid--water (1/2/4)
C4H12N2,2(C7H5O4),4(H2O)
Acta Crystallographica Section B (2001) 57, 3 329-338
a=7.7793(3)Å b=8.1656(3)Å c=9.0662(4)Å
α=104.981(2)° β=97.134(2)° γ=98.066(2)°
1,2-Diaminoethane--3,5-dihydroxybenzoic acid--water (1/2/2)
C2H10N2,2(C7H5O4),2(H2O)
Acta Crystallographica Section B (2001) 57, 3 329-338
a=8.0804(3)Å b=10.6021(6)Å c=11.3988(6)Å
α=90.00° β=109.243(3)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--phosphonoacetic acid (1/1)
C6H12N2,C2H5O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=20.3011(17)Å b=6.7692(5)Å c=8.0158(6)Å
α=90.00° β=90.00° γ=90.00°
2,2'-Dipyridylamine--fumaric acid (1/1)
C10H10N3,C4H3O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=8.0021(4)Å b=8.7178(4)Å c=10.8497(4)Å
α=106.257(3)° β=109.127(3)° γ=98.662(2)°
2,2'-Bipyridyl--fumaric acid (1/1)
C10H8N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=23.9702(6)Å b=3.74160(10)Å c=14.8372(4)Å
α=90.00° β=90.00° γ=90.00°
(1R,3S)-Camphoric acid
C10H16O4
Acta Crystallographica Section B (2003) 59, 1 118-131
a=7.7206(3)Å b=11.6677(5)Å c=12.5830(5)Å
α=90.00° β=105.653(2)° γ=90.00°
Triphenylsilanol--4,4-bipyridyl (1/1)
C18H16OSi,C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=8.9849(3)Å b=9.3118(4)Å c=15.2451(7)Å
α=83.2841(18)° β=89.1384(17)° γ=64.6930(10)°
2,6-Dimethylpiperazine--phosphonopropionic acid--methanol (1/2/0.34)
C6H16N22,2(C3H6O5P1),0.3(CH4O)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=20.2229(17)Å b=8.6162(6)Å c=11.8812(9)Å
α=90.00° β=90.00° γ=90.00°
4,4'-Bipyridyl--phosphonoacetic acid (1/1)
C10H9N2,C2H4O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=4.6225(2)Å b=17.2421(6)Å c=15.6529(7)Å
α=90.00° β=95.7190(15)° γ=90.00°
1,3-trimethylenedipiperidine--phosphonoacetic acid (1/1) methanol/water solvate
2(C13H28N2)2(C2H3O5P),1.58(H2O)0.70(CH4O)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=11.7486(3)Å b=13.3913(4)Å c=13.8206(5)Å
α=96.9260(17)° β=109.4140(16)° γ=105.4830(15)°
Meso-5,5,7,12,12,14-Hexa-C-methyl-1,4,8,11- tetraazacyclotetradecane--phosphonoacetic acid (1/2)
C16H38N4,2(C2H4O5P)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=8.7219(2)Å b=9.89470(10)Å c=9.9343(2)Å
α=62.5110(9)° β=85.6800(8)° γ=67.1910(9)°
2,2'-Dipyridylamine--phosphonoacetic acid (1/1)
C10H10N3,C2H4O5P
Acta Crystallographica Section B (2003) 59, 1 87-99
a=7.0706(2)Å b=10.6500(3)Å c=10.7020(4)Å
α=115.8690(13)° β=98.8120(15)° γ=104.0040(13)°
1,2-Bis(4'-pyridyl)ethane--phosphonoacetic acid (1/2)
C12H14N2,2(C2H4O5P)
Acta Crystallographica Section B (2003) 59, 1 87-99
a=8.8501(3)Å b=15.1862(6)Å c=7.3741(3)Å
α=90.00° β=90.761(2)° γ=90.00°
1,2-Bis(4-pyridyl)ethane--maleic acid (1/2)
C12H14N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=5.7958(3)Å b=9.4489(6)Å c=9.6031(7)Å
α=86.787(3)° β=73.010(3)° γ=76.986(3)°
4,4'-Bipyridyl--maleic acid (1/2)
C10H10N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=24.0370(16)Å b=6.7434(6)Å c=11.4388(10)Å
α=90.00° β=115.996(4)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--fumaric acid (1/2)
C6H14N2,2(C4H3O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=20.1118(9)Å b=6.4737(4)Å c=12.5409(7)Å
α=90.00° β=115.070(2)° γ=90.00°
1,4-Diazabicyclo[2.2.2]octane--fumaric acid (1/1)
C6H13.57N2,C4H2.43O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=9.6845(2)Å b=8.8805(2)Å c=12.5886(2)Å
α=90.00° β=100.0697(15)° γ=90.00°
4,4'-Bipyridyl--fumaric acid (1/1)
C10H8N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=3.8040(2)Å b=8.8743(5)Å c=9.8764(6)Å
α=109.757(2)° β=97.246(3)° γ=96.813(3)°
1,2-Bis(4-pyridyl)ethane--fumaric acid (1/1)
C12H12N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=21.0296(14)Å b=4.7456(3)Å c=16.6875(11)Å
α=90.00° β=118.394(3)° γ=90.00°
4,4'-trimethylenedipyridine--fumaric acid (1/1)
C13H14N2,C4H4O4
Acta Crystallographica Section B (2003) 59, 1 100-117
a=22.4349(15)Å b=4.6045(3)Å c=17.1156(12)Å
α=90.00° β=116.465(3)° γ=90.00°
2,2'-Dipyridylamine--maleic acid (1/2)
C10H10N3,C8H7O8
Acta Crystallographica Section B (2003) 59, 1 100-117
a=11.566(2)Å b=5.4392(11)Å c=14.334(3)Å
α=90.00° β=99.03(3)° γ=90.00°
Hexamethylenetetramine--fumaric acid--succinic acid (1/0.726/0.224)
C6H12N4,0.726(C4H4O4),0.274(C4H6O4)
Acta Crystallographica Section B (2003) 59, 1 100-117
a=6.2877(2)Å b=15.9241(6)Å c=11.3315(5)Å
α=90.00° β=93.8556(13)° γ=90.00°
(1R,3S)-Camphoric acid--1,4-diazabicyclo[2.2.2]octane--water (1/1/1)
C6H13N2,C10H15O4,H2O
Acta Crystallographica Section B (2003) 59, 1 118-131
a=7.0310(3)Å b=11.2520(5)Å c=21.8177(12)Å
α=90.00° β=90.00° γ=90.00°
(1R,3S)-Camphoric acid--piperazine (1/1)
C10H14O4,C4H12N2
Acta Crystallographica Section B (2003) 59, 1 118-131
a=19.1277(4)Å b=7.5743(6)Å c=10.6920(12)Å
α=90.00° β=90.00° γ=90.00°
(1R,3S)-Camphoric acid--1,2-bis(4-pyridyl)ethane (1/1)
C12H12N2,C10H16O4
Acta Crystallographica Section B (2003) 59, 1 118-131
a=8.5318(2)Å b=10.3775(2)Å c=23.3884(5)Å
α=99.8190(8)° β=95.4780(8)° γ=90.7870(9)°
(1R,3S)-Camphoric acid--N,N'-dimethylpiperazine--water (3/1/2)
C10H16O4,2(C10H15O4),(C6H16N2),2H2O
Acta Crystallographica Section B (2003) 59, 1 118-131
a=13.5730(4)Å b=22.0500(8)Å c=6.8417(2)Å
α=90.00° β=90.00° γ=90.00°
1,2-Bis(4'-pyridyl)ethene--phosphonopropionic acid (1/1)
C12H12N22,C12H10N2,2(C3H6O5P)1
Acta Crystallographica Section B (2003) 59, 2 248-262
a=10.1600(3)Å b=10.4061(3)Å c=14.5441(5)Å
α=90.00° β=96.2880(12)° γ=90.00°
2,2'-Dipyridylamine--phosphonopropionic acid--water (1/1/1)
C10H10N31,C3H6O5P1,H2O
Acta Crystallographica Section B (2003) 59, 2 248-262
a=18.7267(11)Å b=22.6805(11)Å c=7.0893(4)Å
α=90.00° β=90.00° γ=90.00°
Piperazine--phosphonopropionic acid (1/1)
C4H12N22,C3H5O5P2
Acta Crystallographica Section B (2003) 59, 2 248-262
a=10.6065(3)Å b=7.9214(2)Å c=12.8892(4)Å
α=90.00° β=94.0540(12)° γ=90.00°
N,N'-Dimethylpiperazine--phosphonopropionic acid--water (1/2/2)
C6H16N22,2(C3H6O5P1),2(H2O)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=6.9270(2)Å b=20.6027(5)Å c=8.0115(2)Å
α=90.00° β=111.4092(10)° γ=90.00°
4,4'-Bipyridyl--phosphonopropionic acid (1/1)
C10H8.82N20.72,C3H6O5.28P0.72=
Acta Crystallographica Section B (2003) 59, 2 248-262
a=11.3482(5)Å b=6.7178(3)Å c=17.7354(7)Å
α=90.00° β=97.4980(18)° γ=90.00°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 0.5
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=9.2128(18)Å b=10.244(2)Å c=19.036(4)Å
α=99.65(3)° β=93.21(3)° γ=99.57(3)°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 1
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=10.1595(19)Å b=18.370(4)Å c=20.490(4)Å
α=66.75(3)° β=77.35(3)° γ=80.95(3)°
Triphenylsilanol--4,4'-bipyridyl (4/1), polymorph with Z' = 4
4(C18H16OSi),C10H8N2
Acta Crystallographica Section B (2003) 59, 2 277-286
a=20.787(4)Å b=24.404(5)Å c=29.456(6)Å
α=83.68(3)° β=89.65(3)° γ=67.11(3)°
(1R,3S)-Camphoric acid--4,4'-bipyridyl (1/1)
C10H16O4,C10H8N2
Acta Crystallographica Section B (2003) 59, 1 118-131
a=6.7302(10)Å b=6.7302(10)Å c=34.345(7)Å
α=90.00° β=90.00° γ=120.00°
1,2-Bis(4'-pyridyl)ethane--phosphonopropionic acid (1/2)
C12H14N22,2(C3H6O5P1)
Acta Crystallographica Section B (2003) 59, 2 248-262
a=7.5651(3)Å b=8.6472(3)Å c=9.0077(4)Å
α=72.6340(14)° β=73.1760(15)° γ=87.386(2)°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetra- azacyclotetradecane--terephthalic acid--water (1/1/4).
C16H38N4,C8H4O4,4H2O
Acta Crystallographica Section B (2000) 56, 1 85-93
a=13.3213(4)Å b=14.0499(4)Å c=16.0491(6)Å
α=90.00° β=110.549(2)° γ=90.00°
Meso-5,5,7,12,12,14-Hexamethyl-1,4,8,11-tetra- azacyclotetradecane--terephthalic acid--water (1/1/6)
C16H38N4,C8H4O4,6H2O
Acta Crystallographica Section B (2000) 56, 1 85-93
a=8.1772(3)Å b=12.3974(4)Å c=16.8804(5)Å
α=90.00° β=116.231(2)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4,4'-thiobiphenol-methanol (1/2/2)
C16H38N42,2(C12H9O2S),2(CH4O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=10.659(5)Å b=17.892(5)Å c=11.679(5)Å
α=90.00° β=103.107(5)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 3-hydroxybenzoic acid-methanol (1/2/2)
C16H38N42,2(C7H5O3),2(CH4O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=8.0814(9)Å b=10.1981(12)Å c=10.7800(16)Å
α=79.789(10)° β=80.728(10)° γ=80.280(10)°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4,4'-tsulfonylbiphenol-methanol (1/2/2)
C16H38N42,2(C12H9O4S),2(CH4O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=10.7736(10)Å b=18.1167(18)Å c=11.5532(14)Å
α=90.00° β=101.136(9)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- phenylphosphonic acid-water (1/4/2)
C16H40N44,4(C6H6O3P),2(H2O)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=8.7391(2)Å b=26.1558(7)Å c=10.7871(2)Å
α=90.00° β=107.267(13)° γ=90.00°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4-hydroxybenzoic acid-methanol (1/2/1)
C16H38N42,2(C7H5O3),CH4O
Acta Crystallographica Section B (2000) 56, 1 39-57
a=9.4481(7)Å b=9.8905(6)Å c=18.0942(12)Å
α=88.704(5)° β=78.675(4)° γ=77.525(4)°
Meso-5,5,7,12,12,14-hexamethyl-1,4,8,11-tetraazayclotetradecane- 4,4'-biphenol (1/3)
C16H38N42,C12H10O2,2(C12H9O2)
Acta Crystallographica Section B (2000) 56, 1 39-57
a=9.9634(10)Å b=18.8981(19)Å c=12.2344(11)Å
α=90.00° β=97.725(7)° γ=90.00°
Bis[(<i>R</i>,<i>R</i>)-1,2-(binaphthylphosphonito)ethane]dichloridoiron(II) dichloromethane disolvate
C84H56Cl2FeO8P4,2(CH2Cl2)
Acta Crystallographica Section E (2020) 76, 9 1525-1527
a=11.9850(3)Å b=11.9850(3)Å c=52.4508(14)Å
α=90° β=90° γ=90°
Diiodido(η^5^-pentamethylcyclopentadienyl)bis(trimethylphosphane)\ iridiumzinc(<i>Ir</i>—–-<i>Zn</i>) benzene hemisolvate
C16H33I2IrP2Zn,0.5(C6H6)
Acta Crystallographica Section E (2019) 75, 12 1824-1827
a=9.5353(7)Å b=10.1962(8)Å c=14.6331(10)Å
α=95.975(2)° β=91.255(2)° γ=114.847(2)°
(Carbonyl-1κ<i>C</i>)(1η^5^-pentamethylcyclopentadienyl)(μ-2,3,9,10-tetramethyl-1,4,8,11-tetrathiaundeca-2,9-diene-1,11-diido-1κ^2^<i>S</i>,<i>S</i>'':2κ^4^<i>S</i>,<i>S</i>',<i>S</i>'',<i>S</i>''')ironnickel(<i>Fe</i>—–-<i>Ni</i>) hexafluorophosphate
C22H33FeNiOS4,F6P
Acta Crystallographica Section E (2018) 74, 9 1222-1226
a=15.4081(3)Å b=18.3762(3)Å c=19.2154(3)Å
α=90° β=90° γ=90°
(+)-<i>trans</i>-Chlorido{2-[(<i>R</i>~p~)-2-(methylsulfanyl)ferrocenyl]-2,5,6,7-tetrahydropyrrolo[1,2-<i>c</i>]imidazol-3-ylidene}bis(triphenylphosphane-κ<i>P</i>)palladium(II) hexafluoridophosphate dichloroform disolvate
C53H48ClFeN2P2PdS,F6P,2(CHCl3)
Acta Crystallographica Section E (2016) 72, 9 1330-1334
a=11.2517(5)Å b=16.4240(10)Å c=31.1181(18)Å
α=90° β=90° γ=90°
(μ~3~-Benzene-1,2-dithiolato)hexacarbonylbis(μ~3~-1,1,1,4,4,4-hexafluorobut-2-ene-2,3-dithiolato)tricobaltmolybdenum
C20H4Co3F12MoO6S6
Acta Crystallographica Section E (2019) 75, 8 1261-1264
a=22.7465(5)Å b=12.8779(5)Å c=23.6033(6)Å
α=90° β=115.3840(16)° γ=90°
Bis(3-methylphenoxy)(phthalocyanine)silicon
C46H30N8O2Si
Acta Crystallographica Section E (2016) 72, 7 988-994
a=10.2566(4)Å b=16.5665(8)Å c=11.5120(5)Å
α=90.00° β=115.860(3)° γ=90.00°
Bis(3-iodophenoxy)(phthalocyanine)silicon
C52H42N8O2Si
Acta Crystallographica Section E (2016) 72, 7 988-994
a=10.9239(3)Å b=25.7282(7)Å c=33.2065(8)Å
α=90.00° β=90.00° γ=90.00°
Bis(2-<i>sec</i>-butylphenoxy)(phthalocyanine)silicon
C44H24I2N8O2Si
Acta Crystallographica Section E (2016) 72, 7 988-994
a=12.6431(6)Å b=19.5870(10)Å c=7.5403(4)Å
α=90° β=103.2220(10)° γ=90°
3-Amino-1,6-diethyl-2,5,7-trimethyl-4,4-diphenyl-3a,4a-diaza-4-bora-<i>s</i>-indacene
C28H32BN3
Acta Crystallographica Section E (2017) 73, 3 378-382
a=9.4938(7)Å b=11.5325(8)Å c=11.3739(9)Å
α=90° β=109.557(2)° γ=90°
4,4-Difluoro-1,3,5,7,8-pentamethyl-2-nitro-4-bora-3a,4a-diaza-<i>s</i>-indacene
C14H16BF2N3O2
Acta Crystallographica Section E (2018) 74, 2 103-108
a=8.2837(9)Å b=8.6660(9)Å c=10.6619(12)Å
α=110.762(3)° β=101.468(4)° γ=95.463(3)°
4,4-Difluoro-3-nitro-8-phenyl-4-bora-3a,4a-diaza-<i>s</i>-indacene
C15H10BF2N3O2
Acta Crystallographica Section E (2018) 74, 2 103-108
a=7.2833(2)Å b=8.5450(3)Å c=11.8803(4)Å
α=81.093(2)° β=74.358(2)° γ=78.581(2)°
3-Chloro-6-ethyl-5,7,8-trimethyl-2-nitro-4,4-diphenyl-4-bora-3a,4a-diaza-<i>s</i>-indacene
C26H25BClN3O2
Acta Crystallographica Section E (2018) 74, 2 103-108
a=11.8359(4)Å b=12.0825(4)Å c=16.5811(5)Å
α=90° β=104.1160(10)° γ=90°
(<i>E</i>)-(Benzylidene)(pyridin-2-ylmethyl)amine
C13H12N2
Acta Crystallographica Section E (2015) 71, 12 o1040
a=9.8029(13)Å b=10.4175(13)Å c=11.4984(15)Å
α=90° β=115.138(4)° γ=90°
Bis(tetra-<i>n</i>-butylammonium) μ-oxalato-bis[bis(1,1,1,4,4,4-hexafluorobut-2-ene-2,3-dithiolato)molybdate(IV)]
2(C16H36N),C18F24Mo2O4S82
Acta Crystallographica Section E (2017) 73, 8 1202-1207
a=14.2347(15)Å b=19.4940(19)Å c=14.4056(14)Å
α=90° β=103.159(5)° γ=90°
Bis(tetra-<i>n</i>-butylammonium) bis(1,1,1,4,4,4-hexafluorobut-2-ene-2,3-dithiolato)oxalatomolybdate(IV)--chloroform--oxalic acid (1/1/1),
2(C16H36N),C10F12MoO4S42,C2H2O4,CHCl3
Acta Crystallographica Section E (2017) 73, 8 1202-1207
a=15.3879(2)Å b=17.8733(5)Å c=22.2895(6)Å
α=90° β=90° γ=90°
Hexakis[μ~3~-1,2-bis(trifluoromethyl)ethene-1,2-dithiolato]-<i>octahedro</i>-hexapalladium(II) benzene 2.5-solvate
C24F36Pd6S12,2.5(C6H6)
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 7 957-962
a=15.6367(15)Å b=17.8970(17)Å c=22.532(2)Å
α=90° β=104.502(2)° γ=90°
Ethyl 3,6-diacetoxy-11-[1-(4- nitrobenzoyloxy)ethyl]tetracyclo[6.4.1.0^2,7^.0^9,12^]trideca-2,4,6,10- tetraene-10-carboxylate
C29H27NO10
Acta Crystallographica Section E (2006) 62, 7 o2846-o2847
a=13.5862(6)Å b=7.3020(3)Å c=14.3462(7)Å
α=90° β=114.709(2)° γ=90°